Labat AfricaJSE:LAB PS Ratio is 0.22 as of Jun. 26, 2026, which is 88% below its 10-year median of 1.86. The stock has 5 warning signs investors should review. Among 953 Drug Manufacturers companies, Labat Africa ranks better than 95.59% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Labat Africa's share price is R0.05.
Labat Africa's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2025 was R0.23. Hence, Labat Africa's PS Ratio for today is 0.22.
The historical rank and industry rank for Labat Africa's PS Ratio or its related term are showing as below:
JSE:LAB'
s PS Ratio Range Over the Past 10 Years
Min: 0.22 Med: 1.86 Max: 8.75
Current: 0.22
During the past 13 years, Labat Africa's highest PS Ratio was 8.75. The lowest was 0.22. And the median was 1.86.
JSE:LAB's PS Ratio is ranked better than 95.59% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.2
vs JSE:LAB: 0.22
Labat Africa Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Labat Africa was 227.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -14.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -23.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 4.70% per year.
During the past 13 years, Labat Africa's highest 3-Year average Revenue per Share Growth Rate was 78.20% per year. The lowest was -55.20% per year. And the median was -15.30% per year.
Back to Basics: PS Ratio
Labat Africa (JSE:LAB) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Labat Africa PS Ratio Related Terms
Labat Africa PS Ratio Historical Data
* Premium members only.
The historical data trend for Labat Africa's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's PS Ratio distribution charts can be found below:
* The bar in red indicates where Labat Africa's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Labat Africa's PS Ratio for today is calculated as
Labat Africa's Share Price of today is R0.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labat Africa's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2025 was R0.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Labat Africa (JSE:LAB) has a PS Ratio of 0.22 as of Jun. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Labat Africa and its competitors. This is 88% below median its historical median of 1.86. Over the past decade, Labat Africa's PS Ratio has ranged from 0.22 to 8.75. According to the industry distribution chart, Labat Africa ranks #42 out of 953 companies in the Drug Manufacturers industry, placing it in the top 4.4%.
Is Labat Africa's PS Ratio too high?
Labat Africa's current PS Ratio of 0.22 is 88% below median its 10-year median of 1.86. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 8.75. The Drug Manufacturers industry median PS Ratio is 2.20. Labat Africa's value of 0.22 is 90% below this industry median. Based on the distribution chart, Labat Africa ranks #42 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #42 out of 953 companies for PS Ratio. This places Labat Africa in the top 4% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.20. Labat Africa's value of 0.22 is 90% below this benchmark. Historically, Labat Africa's own PS Ratio has ranged from 0.22 to 8.75 over the past decade. While the company's 10-year median is 1.86 vs. the industry median of 2.20, Labat Africa has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current PS Ratio of 0.22 is 90% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current PS Ratio is 0.22, which is 88% below median its own 10-year median of 1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current PS Ratio is 0.22, which is 88% below median its 10-year median of 1.86 and 90% below the Drug Manufacturers industry median of 2.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current PS Ratio is 0.22 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 